NTS Ventures y IHMA anuncian programa significativo e importante centrado en la vigilancia de resistencia antifúngica: STAR (Tendencias de susceptibilidad en la resistencia antifúngica)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), un laboratorio de investigación clínica micológica y antifúngica e International Health Management Associates, Inc./IHMA...
NTS Ventures e IHMA anunciam um programa significante e importante focado na vigilância de resistência antifúngica: STAR (Susceptibility Trends in Antifungal Resistance - Tendências de Suscetibilidade na Resistência Antifúngica)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- A NTS Ventures (NTS), um laboratório de pesquisas de micologia e antifúngico, e a International Health Management Associates, Inc./IHMA Europe...
NTS Ventures dan IHMA Mengumumkan Program Signifikan dan Penting yang Memfokuskan Pemantauan Kerintangan Antikulat: STAR (Trend Kerentanan dalam Kerintangan Antikulat)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Illinois, June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), makmal penyelidikan klinikal mikologi dan antifungus serta International Health Management Associates, Inc./IHMA Europe...
NTS Ventures와 IHMA, 항진균성 내성 감시에 초점을 맞춘 중대한 특별 프로그램 발표: STAR(항진균성 내성의 감수성 동향)
June 12, 2019 08:00 ET
|
IHMA Inc
일리노이주 샴버그, June 12, 2019 (GLOBE NEWSWIRE) -- 진균학·항진균 임상연구소 NTS Ventures(NTS)와 풀서비스 중앙 항감염 임상 미생물학 연구소 International Health Management Associates, Inc./IHMA Europe Sàrl(IHMA)가 STAR로 명명된 새로운 항진균성 내성...
NTS Ventures dan IHMA Mengumumkan Program Besar dan Penting yang Fokus pada Pengamatan Resistensi Antijamur: STAR (Susceptibility Trends in Antifungal Resistance)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), laboratorium riset klinis antijamur dan mikologi bersama dengan International Health Management Associates, Inc./IHMA Europe...
NTS Ventures und IHMA geben ein bedeutendes und wichtiges Programm bekannt, das sich auf die Überwachung von Antimykotika-Resistenz konzentriert: STAR (Susceptibility Trends in Antifungal Resistance)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), ein Labor für Mykologie und antimykotische klinische Forschungen und International Health Management Associates, Inc./IHMA...
NTS Ventures et IHMA annoncent un programme significatif et important axé sur la surveillance de la résistance aux antifongiques : STAR (Tendances de susceptibilité de la résistance aux antifongiques)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Illinois, 12 juin 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), un laboratoire de recherche clinique sur la mycologie et les antifongiques, et International Health Management Associates,...
NTS Ventures 及 IHMA 宣布重點關注抗真菌藥物耐藥性監測的重要計劃：STAR（抗真菌藥物耐藥性的易感性趨勢）
June 12, 2019 08:00 ET
|
IHMA Inc
伊利諾伊州紹姆堡, June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS) 是一家真菌學和抗真菌臨床研究實驗室，而國際健康管理協會（IHMA）是一家提供全方位服務中心抗感染性的臨床微生物學實驗室，他們宣布了一項合作協議，將為製藥行業提供一種名為STAR 的全新抗真菌耐藥性監測計劃。除了 NTS 及 IHMA 提供的專業知識外，STAR...
NTS Ventures和IHMA宣布一项重点关注抗真菌耐药性监测的重要计划：STAR（抗真菌耐药性的易感性趋势）
June 12, 2019 08:00 ET
|
IHMA Inc
伊利诺伊州绍姆堡, June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures和IHMA宣布一项重点关注抗真菌耐药性监测的重要计划：STAR（抗真菌耐药性的易感性趋势） 伊利诺伊州绍姆堡，2019年6月12日 (GLOBE NEWSWIRE) -- 真菌学以及抗真菌临床研究实验室NTS Ventures (NTS) 与International Health...
NTS Ventures and IHMA Announce a Significant and Important Program Focusing on Antifungal Resistance Surveillance: STAR (Susceptibility Trends in Antifungal Resistance)
June 12, 2019 08:00 ET
|
IHMA Inc
SCHAUMBURG, Ill., June 12, 2019 (GLOBE NEWSWIRE) -- NTS Ventures (NTS), a mycology and antifungal clinical research laboratory and International Health Management Associates, Inc./IHMA Europe Sàrl...